Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

NCT: NCT06751056 · RECRUITING

NCT IDNCT06751056
StatusRECRUITING
Start Date2025-06-01
Completion2027-01-10
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.

Frequently Asked Questions

What is Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch?

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch is a clinical trial registered under NCT06751056. Current status: RECRUITING.

What is the status of NCT06751056?

The current status of NCT06751056 (Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch) is: RECRUITING.

When did Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch start?

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch started on 2025-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.